Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...
UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold ...
In a joint statement confirming the talks in December, Nissan and Honda said the move could bring about standardised vehicle ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...
Sustainable prospects for the majority of staff at the siteFirst staff takeovers and start of production at KNDS already planned for 2025 5 February, 2025 - The negotiations between Alstom and KNDS De ...
Governor Josh Shapiro presented his $51.5 billion budget address on Tuesday with proposals including legalizing marijuana, ...